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Abstract
The Fukuda et al. criteria is the most widely used clinical case definition for diagnosing patients with chronic fatigue syndrome (CFS). Despite the frequency with
which the Fukuda criteria are applied, the list of symptoms outlined in this case definition were not well enough specified to be easily applied to research settings. In
2005, Reeves et al. laid out a set of standards for operationalizing the Fukuda definition, specifying scales and cutoff scores for measuring the symptom criteria. This
operationalization, often known as the empirical criteria, has been shown to identify an unexpectedly large number of patients, seemingly widening the net of inclusion
for CFS diagnostic criteria. However, in a recent study in 2016 by Unger and colleagues it has been suggested that the 2005 Reeves et al. 2005 operationalization of
the Fukuda criteria does not over-identify the number of patients with CFS as had been previously reported. This article reviews prior studies which provide context
for these findings and offers a possible explanation for the discrepancies. Clearly, determining what case definition to use and how to operationalize it remains an
important activity for scientists in this field, as it will influence work in multiple domains, including etiology, pathophysiology, epidemiology and treatment.

The implications of using a broad versus narrow set of
criteria in research
Although the Fukuda criteria [1] are widely as a research case
definition for diagnosing patients with chronic fatigue syndrome
(CFS), the symptoms and other characteristics outlined in Fukuda
were not well enough specified to be easily and reliably applied across
a variety of settings. In an effort to resolve this problem, Reeves and
colleagues in 2005 [2] laid out a set of standards for operationalizing
the Fukuda case definition, specifying scales and cut off scores for
assessing the symptom criteria. This operationalization, often known
as the “empirical criteria,” had been shown to identify an unexpectedly
large number of patients [2], seemingly widening the net of inclusion
for the Fukuda case definition. However, recently, Unger and
colleagues [3] have published an article revisiting the 2005 Reeves
et al. operationalization as well as examining the issue of increased
prevalence rates from the 2007 study by Reeves and colleagues [4].
We review these new findings, putting them in context and trying to
highlight some of the reasons for the dramatic shifts in CFS prevalence
rates across various studies.
Most notably, the Center for Disease Control (CDC) estimates of
CFS prevalence rates have increased dramatically over the years. In
2003, Reyes et al. published a prevalence study using the traditional
approach to diagnosing CFS via Fukuda and found a prevalence rate
of .24% in Wichita, Kansas [5].1 This rate was somewhat comparable
to a previous population prevalence study in Chicago, which found a
rate of .42% [6], again using the traditional approach to the Fukuda
criteria. However, in a subsequent CDC population based study in
Georgia, using the 2005 Reeves et al. empirical criteria, Reeves and
colleagues concluded that the CFS prevalence rate had risen to 2.54%
[4], which represents a 10-fold increase compared to the earlier CDC
estimates. One explanation for the 10-fold increase is that cases of CFS
did indeed increase over time, though this seems unlikely. When Jason
and colleagues [7] conducted a follow-up to their original community-

J Med Therap, 2017

doi: 10.15761/JMT.1000116

based prevalence study [6] using the same traditional approach to
diagnosing with the Fukuda criteria, they found that 10 years later
CFS prevalence rates had remained relatively stable [7]. In light of this,
other explanations for the increase in CDC prevalence rates need to be
explored.

CDC prevalence studies
It is, therefore, important to revisit the earlier studies conducted by
the CDC to better understand the differences in methodological design
that could have led to these the prevalence rate discrepancies. The first
CDC prevalence study using the Fukuda criteria was conducted by
Reyes and colleagues [5] from 1997 to 2000 in Wichita, Kansas, and
involved 56,146 adults who participated in a structured interview via
telephone. Those who reported experiencing CFS-like symptoms,
including fatigue and at least 4 of the required Fukuda symptoms (n
= 299) were brought into a clinic for a comprehensive assessment. Of
those assessed in person at the clinic, 141 participants were found to
have medical/psychiatric exclusions which explained their fatigue with
other diagnoses, and 43 were diagnosed with CFS. This final total of 43
patients with CFS out of the 56,146 participants screened resulted in
the reported prevalence rate of .24%.
In 2002 and 2003, Reeves and colleagues evaluated 227 participants
from the original Wichita sample who had agreed to participate
in a clinical follow-up study [2]. During the original Wichita study,
participants had been followed at regular intervals for four years. A total
of 70 individuals from the original sample were diagnosed with CFS at
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least once during this 4-year period. Fifty-eight of these 70 agreed to
be medically and psychiatrically evaluated and were included in the
Reeves et al.’s 2005 study [2] follow-up sample of 227. The remainder of
the 227 consisted of 55 matched controls; a group of 59 individuals who
reported fatigue, but did not meet a sufficient number of criteria to be
diagnosed with CFS; and 55 individuals with melancholic depression
and some level of fatigue. This follow-up study used two different
approaches to classifying participants, both of which were based on
the Fukuda criteria. The first approach followed the same interview
question protocol used for classifying participants in the 2003 Reyes
et al. study and was labeled the “surveillance criteria.” This approach,
which we refer to as the “traditional approach,” used an interview
protocol asking about specific symptoms associated with the Fukuda
case definition. The second method used a series of questionnaires
and cutoff criteria aimed at reliably operationalizing the Fukuda case
definition. The authors called this approach the “clinically empirical
definition,” which we will refer to as the empirical criteria. However,
they found little agreement between these two classification systems.
The traditional method, or “surveillance criteria” only classified 16
individuals as having CFS, whereas 43 were diagnosed with CFS using
the empirical criteria [2]. Clearly, the empirical criteria identified
considerably more individuals with CFS than the traditional approach.
The next community-based CDC prevalence study was conducted
in Georgia from 2005-2006 and published by Reeves et al. in 2007 [4].
Again, this study used the empirical criteria. In the Georgia study,
about half as many individuals were initially interviewed (N = 19,381),
compared to the original Reyes et al. Wichita study (N = 56,146) [5].
After the initial telephone interviews, Reeves et al. [4] identified a total
of 292 participants with CFS-like symptoms (versus 299 in the Wichita
study). In addition to those with CFS-like symptoms, a randomly
selected set individuals from other illness categories were also invited
for clinical evaluation: 1) chronically unwell (i.e., ill for 6 months or
more with or without fatigue but not classified as having CFS-like
symptoms; n = 268) 2) prolonged unwell (i.e., unwell for less than 6
months; n = 60); and 3) well (n = 163).
Of the 292 participants with CFS-like symptoms, 141 were
excluded for medical/psychiatric reasons (equal to the 141 in the
Wichita study), and 84 individuals were diagnosed with CFS (versus
43 in the Wichita study). In fact, the Georgia study found about twice
the number of individuals with CFS as did the Wichita study and
did so with a sample less than half the size. When the Reeves group
examined the wider set of clinic participants who had not initially selfreported CFS-like symptoms, they identified several more CFS cases
[4]. The chronically unwell group yielded 26 CFS cases; the prolonged
unwell group yielded 2 cases, and the well group yielded 1 case, for a
final total of 113 individuals identified as having CFS. To summarize,
using a considerably smaller sample, the Georgia study [3] identified
many more patients with CFS when using the empirical criteria, which
equates to a 10-fold in prevalence estimates between the .24% rate from
the 2003 Reyes et al. study [5] and the 2.54% rate from Reeves and
colleagues 2007 study [4].
Most recently, Unger et al. [3] used follow-up data collected between
2007 and 2009 from the same Georgia study sample to comprehensively
evaluate 751 individuals in a clinic. Of the 751, a subgroup of 499
were eligible for inclusion in a comparison of two diagnostic methods
(249 had been excluded due to medical/exclusionary conditions, and
3 were excluded due to incomplete data). Both diagnostic methods
were based on the Fukuda case definition. The first method used the
same traditional approach as used in the 2003 study by Reyes and
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colleagues [5]. This approach used an interview protocol that directly
questioned participants about symptoms and then made diagnostic
determinations based on their self-report symptoms. The second
approach used the set of standardized questionnaires and related cut
points established by Reeves and colleagues [2]. While Reeves et al. [2]
used the label “clinically empirical criteria,” Unger et al. [3] referred
to this as the “Georgia method,” (we will continue to use “empirical
criteria” when discussing this approach). Unger and colleagues found
that 71 of their 499 eligible participants (14%) met CFS criteria using
the empirical criteria, whereas 59 (12%) met diagnostic criteria using
the traditional approach [3]. The 12 additional individuals identified as
having CFS using the empirical criteria represents only a small increase
in the number of diagnoses compared to the traditional method [3].
Based on these findings, Unger and colleagues have suggested
that “The two methods demonstrated substantial concordance”
[3], suggesting that there are no substantial differences between
the traditional approach to evaluating the Fukuda criteria versus
the empirical criteria. If this is the case, it would be important to
understand why CDC estimates of CFS prevalence rates have fluctuated
so dramatically between the 2003 Reyes et al. study [5] and the 2007
Reeves et al. study [4] that reported prevalence rates that are 10-fold
higher.

Explaining variation in prevalence estimates
Unger and colleagues identified a number of issues that attempt
to explain the large increase in prevalence estimates for CFS marked
by these two previous studies. We focus on several of the major issues
laid out in the Unger et al. article [3] as well as some additional issues
in an attempt to differentiate Reyes et al.’s 2003 Wichita study [5] and
the Georgia studies [3,4]. More minor issues in the Unger study are
covered elsewhere2.

Study inclusion
The first issue is related to the method by which participants
were selected for both prevalence studies [4,5]. The Georgia study by
Reeves et al. in 2007 [4] expanded the screening criteria required for
enrollment in the clinical valuation phase from only requiring fatigue
to enrolling a larger subset of all those who had reported one or more
of the four major core symptoms of the syndrome: fatigue, cognitive
impairment, unrefreshing sleep, and pain. However, this alone cannot
explain the 10-fold increase in prevalence rates. In fact, Reeves and
colleagues [4], in the original Georgia study noted that only “11.5%
of subjects with CFS would not have been detected in previous studies
that queried participants only for fatigue.”

Operationalization
A second issue relates to the instruments and cutoffs utilized in
the empirical criteria. The 2007 Reeves et al. study [4] used empirical
criteria that involved standardized instruments and cut offs compared
to the traditional method, possibly accounting for some of the
discrepancies. It could be possible that the 10-fold increase in CFS
prevalence could be partly accounted for by differences in the two
methods of diagnosing patients. It is, therefore, important to examine
the standardized instruments used in the 2005 Reeves et al. empirical
criteria [2] in order to better understand what might have led to the
increased estimation of prevalence rates.
Reeves et al. [2] recommended the use of the Medical Outcome
Survey Short-Form-36 (SF-36; [8]), Multidimensional Fatigue
Inventory (MFI;[9]) and the CDC Symptom Inventory (SI; [10]) to
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implement the empirical criteria. Reeves et al. [2] used the SF-36, along
with norms-based cutoff scores, in order to operationalize disability.
To meet the empirical criteria for substantial reduction, individuals
only needed to score in the lower 25th percentile on one of four specific
SF-36 subscales. One of the four SF-36 subscales assessed includes the
role emotional scale, which measures issues such as problems with
work or other daily activities that stem from emotional issues. Ware
and Sherbourne [8] found that the mean score for the role emotional
subscale for a group with clinical depression was 38.9. Almost all those
with clinical depression would meet the CFS empirical criteria for
substantial reduction (i.e., at or below the lower 25th percentile on this
scale, defined as a score of less than or equal to 66.7).
In addition to assessing substantial reduction via the SF-36
disability measure, the empirical criteria also measured other key
CFS symptoms using the CDC Symptom Inventory, which gathers
information about symptom occurrences within the past month rather
than the past six months as had been required by the Fukuda case
definition. Most importantly, this instrument was scored in a way that
did not require several key symptoms for CFS, which include postexertional malaise, unrefreshing sleep, and cognitive impairment. In
the CDC Symptom Inventory, each symptom is given the same value.
For example, a participant reporting severe and frequent headaches
would be assigned the same value as a participant reporting severe and
frequent post-exertional malaise. In fact, using the Fukuda criteria, an
individual might not have any of the symptoms repeatedly shown to be
core and critical symptoms of CFS, yet could still be diagnosed with the
illness. However, this critique would apply to both the traditional and
empiric method for diagnosing patients with CFS.
Finally, the 2005 Reeves et al. empirical criteria [2] used the
Multidimensional Fatigue Inventory (MFI; [9]) to measure fatigue.
Jason and colleagues [11] have since shown that 74% of a group
identified as having major depression would meet the 2005 Reeves et al.
empirical criteria for fatigue using the MFI. For example, an individual
with depression could meet CFS criteria by answering true to the
following MFI items: “I get little done” or “I do very little in a day,”
while also answering negatively to “I feel very active” or “I think I do
a lot in a day.” It is, therefore, relatively common for individuals with
depression to meet the empirical criteria for both disability and fatigue.

Possible inclusion of patients with solely psychiatric
conditions
One possible reason for the prevalence discrepancies involves the
means by which these instruments assess for psychiatric problems.
Specifically, it is possible that individuals with a purely affective
illness, such as Major Depressive Disorder (MDD), might have been
included in the increased estimates. The CDC CFS prevalence rate of
2.54% [4] is remarkably comparable to the prevalence rate of MDD
[12]. For major depressive episode, the one-month prevalence is 2.2%,
and lifetime prevalence is 5.8%. A person with primary MDD could be
misdiagnosed with CFS, as people with MDD often experience chronic
fatigue and several of the other minor symptoms, such as unrefreshing
sleep, joint pain, muscle pain, and impairment in concentration. To
address this, in the past, our research group performed an investigation
that found it possible to discriminate with 100% accuracy between CFS
and individuals with MDD, using instruments that differentiate these
conditions [13].
Because it is possible that those with a purely affective disorder
might be inappropriately diagnosed with CFS, our research team
conducted a study to clarify this situation. Jason and colleagues [11]
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found that 38% of a group with a primary affective disorder (i.e., MDD)
would have been misdiagnosed with CFS using the 2005 Reeves et al.
empirical operationalization of the CFS case definition. In another
study [14] , when using all three of Reeves et al.’s empirical criteria
for 1) fatigue, 2) symptoms and 3) disability, the sensitivity was at an
unacceptably low level of .65. In other words, only 65% of true CFS
cases were identified, suggesting that the empirical criteria were not
able accurately to identify individuals who have this illness.
An accurate case definition must reliably exclude psychiatric
confounds. Studies conducted by researchers not affiliated with the
CDC are worth noting in this regard in comparison to the varying
prevalence estimates published by the CDC. British studies [e.g.,
15] have found a CFS prevalence rate of 2.6% (similar to [4]), but if
psychological disorders were excluded from the British study, the CFS
prevalence rate drops to only .5% in this sample. Other work [16] has
compared those diagnosed with CFS in the Britain study [15] to a CFS
sample from a hospital unit. Euba and colleagues [16] found that 59%
of the community sample reported thinking their illness might be
due to psychological or psychosocial causes, whereas only 7% of the
hospital sample expressed this view.
Additionally, in a recent Institute of Medicine (IOM) report on
CFS [17], the authors reviewed a study by Heim and colleagues [18]
involving the role of childhood trauma in ME/CFS. Heim et al. [18]
used the 2005 Reeves et al. empirical criteria [2], prompting the IOM
panel to suggest that the use of these criteria resulted in a biased
sample with overrepresentation of individuals with depression and
posttraumatic stress disorder (PTSD). The panel also proposed that
the high proportion of patients with serious psychiatric problems likely
explained the study finding of an association between CFS and adverse
childhood experiences [17].
It is possible that Unger and colleagues [3] were successful in
eliminating psychiatric confounds, as they incorporated a number
of methods to screen out these exclusionary conditions. Indeed, only
one of the CFS cases they identified was diagnosed with moderate to
severe depression. If this most recent iteration of the empirical criteria
was successful in screening out those with exclusionary illnesses, then
this might help explain why the two diagnostic methods (i.e., the
traditional approach and the empirical approach) in the Unger et al.
[3] study resulted in the identification of a fairly similar number of
CFS cases. However, many, if not most, ongoing CFS studies do not
include structured clinical interviews aimed at identifying exclusionary
psychiatric problems and ruling out the other potential causal factors.

Identification of core features of the illness
Another important issue is whether individuals with CFS are being
correctly identified in these epidemiological studies. It is also possible
that the Unger et al.’s study [3] did not include individuals who have
the core symptoms or characteristics of CFS. In the Unger et al. study
[3], only 10-11% of the CFS group reported a sudden onset, whereas in
most tertiary clinics sudden onset is predominate [19]. Additionally, of
the individuals who were classified as having CFS using the 2005 Reeves
et al. empirical criteria [2], only 52% met the physical functioning
disability criteria. In addition, only 77.8% were identified as having
post-exertional malaise of 6 months or longer and 25.93% as having
memory or concentration problems lasting for six months or longer
(although rates are somewhat higher when including those who met
either the traditional or empiric criteria). These levels of key symptoms
are unusually low, indicating the inclusion of a high proportion of CFS
cases that are missing key symptomology.
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In fact, both the Fukuda case definition and the Reeves et al.
empirical operationalization do not require several cardinal symptoms
including post-exertional malaise, memory and concentration
problems, and unrefreshing sleep. A recent review of 53 studies that
used the Fukuda criteria for diagnosing CFS found that these three
critical symptoms were detected among the groups identified as having
CFS at variable rates: post-exertional malaise ranged from 25-100%,
neurocognitive deficits from 16-100%, and unrefreshing sleep from
16-100% [20]. It is possible that those patients with CFS identified by
the Fukuda criteria do not consistently report these core symptoms.
For example, consider two hypothetical patients who meet the Fukuda
criteria: Patient 1 has a sore throat, tender lymph nodes, joint, and
muscle pain but not unrefreshing sleep, memory and concentration
problems, and post-exertional malaise. Patient 2 has unrefreshing sleep,
memory and concentration problems, and post-exertional malaise. The
fact that both patients would be diagnosed with CFS using the Fukuda
case definition shows the potential variability among this group of
identified patients, who may experience only partially overlapping, or
entirely non-overlapping core symptoms. Any attempt at creating an
accurate research case definition would need to include the cardinal
symptoms of the illness.
This problem of identifying patients who have classic CFS
characteristics also occurred in the CDC community-based
epidemiology study in Wichita, Kansas [5,21], 58 individuals who
identified as having CFS during the first wave from 1997 through 2000,
were brought back for a two day inpatient study that occurred from
2002 to 2003. Only 16 of these 58 (28% of the original group diagnosed
with CFS) had a current consistent diagnosis of CFS at the follow-up.
Recovery is not a likely explanation for this, as evidence suggests that
the proportion of patients who recover is smaller [22]. It could be
that the use of Fukuda, a fairly broad case definition, resulted in the
identification of cases that differed substantially from what is typically
seen in tertiary settings.

The role of lifestyle factors
Perhaps the most important factor worth consideration in
understanding changes in the prevalence rates is whether there
are understandable lifestyle explanations for the fatigue and other
symptoms experienced by some of the patients in the 2007 Reeves et al.
sample [4] and 2016 Unger et al. sample [3]. In today’s society, many
individuals are exhausted from working multiple jobs while meeting
challenging family responsibilities, and as may experience cognitive
and fatigue problems a result. Many of these individuals report high
levels of symptoms, and if the evaluators are not extremely careful, some
could be inappropriately classified as having CFS using the empirical
criteria. Therefore a variety of factors, in addition to psychiatric issues,
can result in CFS-like symptoms. These include but may not be limited
to: medication side effects, poor sleep hygiene, weight, poor diet,
deconditioning, and inactivity. It would be important for any research
case definition to assess for and exclude these causes of fatigue. For
instance, the empirical criteria does not seem to have a mechanism
for excluding those whose fatigue and symptoms were due to ongoing
excessive exertion.
Additionally, there is likely to be a good amount of variability in
how this case definition is used. In particular, the potential for variation
in the methods used to assess substantial reduction has not yet been
adequately explored. Operationalizing key concepts outlined in the
Fukuda criteria is important. For example, it would be useful to find a
reproducible way to specify fatigue as outlined in Fukuda [1]: “chronic
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fatigue that is of new or definite onset (i.e., not lifelong). The fatigue
is not the result of ongoing exertion. The fatigue is not substantially
alleviated by rest.” To this end, others have outlined a way to define
“lifelong,”3 which is indeed a challenging task [23].
Let’s examine how Unger and colleagues [3] operationalized “not
substantially alleviated by rest.” First the person would need to answer
“no” to fatigue was made a lot better by rest to fulfill this requirement.
But if they responded “yes” to fatigue was made a lot better by rest,
they could be included if their fatigue was relieved by rest “some of
the time,” “a little of the time,” “or hardly ever.” They would be not
included if they said that their fatigue was relieved by rest “all of the
time” or “most of the time.” The problem with this approach stems
from the fact that much of the time, rest does relieve fatigue symptoms
for many patients with CFS. However, for these patients, rest is not fully
curative and does not increase the stamina and endurance necessary to
carry on life tasks. Therefore, while it is important to operationalize this
part of the Fukuda case definition, it is critical to do so in a way that
distinguishes between those who’s rest fully eliminates the symptom
complex and those form whom this does not occur (e.g., patients with
CFS). It is equally important to determine if CFS induced fatigue is
result of ongoing exertion. The failure of the Unger et al. article [3]
and the empiric criteria to address this key issue of ongoing exertion
causing the fatigue is problematic. In other words, unless questions
have been carefully crafted and validated, a person could meet the CFS
diagnosis whose fatigue is mainly due to excessive exertion, and with
lifestyle issues such as being over-committed.

The IOM case definition
A new case criteria for CFS was recently proposed by the IOM [17],
and it does specify the 4 cardinal symptoms of CFS for inclusion in
their new clinical criteria: 1) substantial reduction or impairment in
the ability to engage in pre-illness levels of occupational, educational,
social or personal activities; 2) post-exertional malaise; 3) unrefreshing
sleep; and 4) at least one of the two following symptoms: cognitive
impairment or orthostatic intolerance. While this approach does
recognize the importance of the key symptoms, in practice it is
vulnerable to other problems.
First, the IOM case definition [17] is different from the previous
Fukuda et al. [1] and Carruthers et al. [24] case definitions in
classifying psychiatric and medical issues as co-morbidities instead of
exclusionary conditions. Using a community based sample that had
not been screened for exclusionary illnesses, Jason and colleagues [25]
estimated the IOM prevalence rate would be 2.8 times greater than
past estimates using the traditional approach to the Fukuda criteria.
This major discrepancy was the result of the new IOM clinical criteria
including 47% of those with Melancholic Depression and 48% of those
with a medical reason for their fatigue. In other words, the expansion
of the CFS case definiton that has occurred with the 2005 Reeves et
al. empirical criteria may likely continue with the deletion of the
exclusionary criteria in the IOM recommendation.
These issues suggest that the clinical IOM criteria [17] are not to
be used as a research case definition for CFS. While many researchers
will continue to use the Fukuda case definition as a research criteria,
some may now begin using the IOM clinical criteria for research
purposes. Some researchers may feel that it is acceptable to use a variety
of research criteria as long as definitions and methods are adequately
explained in publication. However, this reduces the possibility of
comparisons across studies or research labs, as each research group
is likely to apply these different criteria in a variety of approaches to
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diagnosing CFS. Alternatively, and toward the end of reducing the
impact of this limitation, the research community might select one
research criteria, either an empirically based one (though not the 2005
Reeves et al. criteria [2]), the Myalgic Encephalomyalitis-International
Consensus Criteria (ME-ICC), the Canadian Consensus Criteria
(CCC), the Ramsay Criteria, or the IOM clinical criteria with more
extensive and concretely specified exclusions.

Conclusion
In this article, we have outlined the issues that should be considered
and addressed in order to develop the kind of case criteria that could
be reliably used across studies to accurately identify a homogeneous
group of individuals with CFS. We believe it is critically important
that research related to CFS is capable of reliably identifying a group of
individuals with the illness, without including cases that confound CFS
with other issues such as psychiatric disorders, medical conditions,
and lifestyle issues. The discrepancies in prevalence estimates across
the different studies outlined above may be related to the extent to
which each study included or excluded these confounding issues
in their assessment of CFS cases. If there are ambiguities with case
definitions and improper operationalization of criteria, research aimed
at accurately identifying individuals with CFS will continue to produce
fundamentally different samples, resulting in difficulties replicating
findings across different labs, estimating the prevalence of the illness,
consistently identifying biomarkers, and determining which treatments
help patients. In addition to a focus on reproducible operationalization
of key elements, there is a need to develop a consensus about what
research case definition to use.

Foot notes
1
These rates were considerably higher than a prior CDC study,
which found considerably lower rates from 0.004% to 0.0087% [26] but
as this study used a different CFS case definition, we will limit our focus
on those studies using the Fukuda et al. [1]criteria.

Below are several more minor issues that are discrepancies from
the original Reeves et al. [4] paper and the recent paper by Unger et
al. Reeves et al. completed 5,623 interviews representing 3 groups
of individuals who were unwell without fatigue, unwell with fatigue
and well. However, on page 3 of Unger et al. [3] it is stated that 5,630
were interviewed. The number 5,630 came from an article by Decker
et al. [27], and the numbers do not match what was reported in the
Reeves et al. article. We are informed that in the Unger et al. study,
783 had a baseline medical examination, but in the Reeves et al. paper,
the number is 781 (280 with exclusionary illnesses and 501 without).
Finally, we are informed in the Unger et al. study that of those eligible
for the 2007-2009 study, 681 participants were included who had been
seen in the clinic without permanent exclusions [4] study indicates that
there were only 501 individuals seen in the clinic without exclusionary
illnesses).
2

Initially, participants’ responses to the question, “Have you always
had persistent or recurring fatigue/energy problems, even back to your
earliest memories as a child?” (Question 67 in the DSQ) were noted.
Of the participants who answered “Yes” to this question, responses to
two additional questions related to lifelong fatigue were considered.
The question “How long ago did your fatigue/energy problem begin?”
indicated whether participants remembered a time prior to their illness,
and the question “Over what period of time did your fatigue/energy
related illness develop?” indicated whether their illness had a new or
definite onset (Questions 69 and 77 in the DSQ). Based on responses
3
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to these two questions, participants with suspected lifelong fatigue
were re-contacted and asked five additional questions about the onset
of their illness: (1) Around what age did your fatigue/energy-related
illness begin? (2) When did you first begin to experience symptoms? (3)
Even if you have always dealt with fatigue/energy problems, was there a
point of “onset” of your illness, or a time when your symptoms became
significantly worse? (4) In the case that you do not remember a time
without fatigue/energy problems, have friends or family ever told you
that there was a time when you did not have fatigue/energy problems?
(5) Are there other relevant details we should know about the timing or
onset of your fatigue/energy-related illness? Responses to these openended questions provided the information needed to determine which
participants truly had lifelong fatigue.
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